Real-time enrollment status for this ulcerative colitis clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:49 AM UTC
| NCT Number | NCT07012395 |
| Recruiting Status | Recruiting |
| Condition | Ulcerative Colitis |
| Phase | PHASE2 |
| Target Enrollment | 645 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Spyre Therapeutics, Inc. |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT07012395 is currently recruiting participants. This phase2 study for ulcerative colitis is actively seeking new participants at 26 locations across the United States. The study is sponsored by Spyre Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07012395 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07012395 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.